Compare NEPH & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEPH | VATE |
|---|---|---|
| Founded | 1997 | 1994 |
| Country | United States | United States |
| Employees | 31 | N/A |
| Industry | Medical/Dental Instruments | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.0M | 70.3M |
| IPO Year | 2004 | 1996 |
| Metric | NEPH | VATE |
|---|---|---|
| Price | $5.43 | $5.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 77.9K | 14.9K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | $17,930,000.00 | ★ $1,099,900,000.00 |
| Revenue This Year | $33.32 | N/A |
| Revenue Next Year | $12.27 | N/A |
| P/E Ratio | $40.69 | ★ N/A |
| Revenue Growth | ★ 32.36 | N/A |
| 52 Week Low | $1.39 | $4.05 |
| 52 Week High | $6.42 | $13.79 |
| Indicator | NEPH | VATE |
|---|---|---|
| Relative Strength Index (RSI) | 50.82 | 42.08 |
| Support Level | $5.06 | $4.76 |
| Resistance Level | $5.97 | $5.24 |
| Average True Range (ATR) | 0.58 | 0.23 |
| MACD | 0.04 | -0.04 |
| Stochastic Oscillator | 38.54 | 15.40 |
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.